Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
80.51%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 2.37Close
$ 1.1 - $ 6.45 52-Week Range
Ticker Information
Ticker
CCCCCompany Name
C4 THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQC4 THERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CCCC - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 34.24M | $ 27.57M | 80.51% |
| 3/31/2025 | $ 39.78M | $ 28.95M | 72.78% |
| 12/31/2024 | $ 35.58M | $ 29.66M | 83.36% |
| 9/30/2024 | $ 33.67M | $ 27.79M | 82.53% |
| 6/30/2024 | $ 29.38M | $ 27.16M | 92.43% |
| 3/31/2024 | $ 20.04M | $ 27.2M | 135.75% |
| 12/31/2023 | $ 20.76M | $ 27.23M | 131.22% |
| 9/30/2023 | $ 20.35M | $ 27.8M | 136.59% |
| 6/30/2023 | $ 16.03M | $ 25.61M | 159.73% |
| 3/31/2023 | $ 27.2M | $ 27.33M | 100.47% |
Key Performance Insights, Last 5 Years
- C4 THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 10.34%.
- Over the past 5 years, C4 THERAPEUTICS INC's average SB Comp % has been 83.09%.
- The median SB Comp % for C4 THERAPEUTICS INC during this period was 81.52%
- C4 THERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 159.73%.
- The lowest SB Comp % recorded by C4 THERAPEUTICS INC in the same timeframe 10.34%
C4 THERAPEUTICS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for C4 THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 3.43M ] / Revenues [ $ 33.2M ]
(=) SB Comp % [ 10.34% ] CCCC - Stock Based Compensation Margin, Last 5 years
10.34%
Minimum
Dec 31, 2020
159.73%
Maximum
Jun 30, 2023
83.09%
Average
81.52%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |